| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,580 |
5,442 |
$327K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,761 |
1,744 |
$256K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,877 |
2,877 |
$216K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,106 |
1,105 |
$128K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,073 |
1,060 |
$88K |
| 99205 |
Prolong outpt/office vis |
157 |
157 |
$24K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
330 |
330 |
$18K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
325 |
322 |
$16K |
| 99215 |
Prolong outpt/office vis |
76 |
75 |
$8K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
276 |
276 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
764 |
755 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
61 |
55 |
$2K |
| 0011A |
|
39 |
39 |
$1K |
| 0012A |
|
38 |
38 |
$1K |
| 0002A |
|
36 |
35 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
26 |
26 |
$1K |
| 0001A |
|
21 |
21 |
$827.49 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
66 |
65 |
$666.54 |
| 87081 |
|
28 |
28 |
$187.88 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
12 |
12 |
$182.04 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
92 |
91 |
$118.09 |
| 36415 |
Collection of venous blood by venipuncture |
19 |
19 |
$49.35 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
66 |
65 |
$12.35 |
| 99000 |
|
48 |
48 |
$3.93 |
| 99072 |
|
124 |
123 |
$0.00 |